Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/1997
10/23/1997WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997WO1997038705A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997CA2251797A1 Novel peptides and nootropic agent
10/23/1997CA2251292A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/23/1997CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997EP0801655A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
10/22/1997EP0801654A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa
10/22/1997EP0485458B1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same
10/22/1997CN1162921A A storage stable water solution for infusion containing a thrombin inhibitor
10/22/1997CN1036201C Process for separating alpha-L-aspartyl-L-methyl phenylalaninate
10/21/1997US5679797 Retroviral protease inhibiting compounds
10/21/1997US5679687 Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof
10/21/1997US5679671 Angiotensin 1-converting enzyme inhibitor, vasopressin antagonism and atrial nautriuretic peptide hydrolase inhibitor
10/21/1997US5679643 Glutathione analogs and paralog panels comprising glutathione mimics
10/21/1997CA2030433C New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
10/16/1997WO1997038134A1 Method for detecting a target compound using a nucleic acid ligand
10/16/1997WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors
10/16/1997WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997WO1997030975A3 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
10/16/1997WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0|heptan-7-one derivatives as cysteine protease inhibitors
10/16/1997CA2250525A1 Method for detecting a target compound using a nucleic acid ligand
10/16/1997CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/15/1997EP0801073A2 Process for the production of oligopeptid-aldehydes
10/15/1997EP0800528A1 Peptide and peptide analog protease inhibitors
10/15/1997EP0800527A1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
10/15/1997CN1162318A New peptide active substance and production thereof
10/14/1997US5677448 Sulfonamidocarboxamides
10/14/1997US5677297 Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/14/1997US5677283 Antiinflammatory agents, nervous system disorders
10/14/1997US5677282 Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase
10/14/1997US5677281 Use of peptide derivatives for the preparation of medicaments inhibiting endopeptidases 24.15 and 24.16
10/14/1997US5677195 Forming oligonucleotides or peptides by forming flow channels in substrate surface, each of flow channels comprising walls which form fluid-tight seals with surface and a flow intake and outlet, flowing nucleic acids through channels to bind
10/09/1997WO1997037228A1 Methods for diagnosing and treating alzheimer's disease
10/09/1997WO1997037225A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+-DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF
10/09/1997WO1997036922A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997WO1997036873A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
10/09/1997CA2249716A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/08/1997EP0799241A1 Peptides having immunomodulatory activity
10/08/1997EP0799240A1 Heterocyclic keto arginine peptides as thrombin inhibitors
10/08/1997EP0799052A1 New antithrombotic formulation, process for its manufacturing, and use thereof
10/08/1997EP0777679A4 Delivery of nucleic acids
10/08/1997EP0648740B1 Amino acid amide derivative, agrohorticultural bactericide, and production process
10/08/1997EP0629212B1 New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
10/07/1997US5674979 Agent for inhibiting symmetrical proteins, in particular enzymes
10/07/1997US5674976 Coupling first modular component to third modular component to yield precyclized gamma turn mimetic, cyclizing
10/07/1997US5674905 Administering as gastrin or cholecystokinin antagonists
10/07/1997US5674890 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
10/07/1997US5674882 Retroviral protease inhibiting compounds
10/07/1997US5674676 HCV peptide antigens and method of determining HCV
10/02/1997WO1997035990A2 Histone deacetylases, and uses related thereto
10/02/1997WO1997035875A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/02/1997WO1997035874A1 Process for the preparation of n-methyl-d-phenylalanyl-n-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3-difluoro-2-oxohexyl]-l-prolinamide
10/02/1997WO1997019675A3 Complex cationic lipids
10/01/1997EP0797583A1 Tachykinin antagonists
10/01/1997CN1161058A Intracellular isoform of the interleukin-1 receptor antagonist
09/1997
09/30/1997US5672681 Conformationally restricted mimetics of gamma turns and peptides containing the same
09/30/1997US5672599 Compounds containing a fused bicycle ring
09/30/1997US5672598 Matrix metalloprotease inhibitors
09/30/1997US5672596 Animal growth controllers
09/30/1997US5672584 Modified with end groups
09/30/1997US5672582 Anticoagulants; 4-substituted cyclohexylamine derivatives
09/30/1997US5672581 Drug delivery; aerosol, programmed, portable, disposable
09/25/1997WO1997034924A1 Process and intermediates for the synthesis of lhrh antagonists
09/25/1997WO1997034923A1 Process and intermediates for the synthesis of lhrh antagonists
09/25/1997WO1997034604A1 4-spiroindoline piperidines promote release of growth hormone
09/25/1997WO1997027220A3 Substrates and inhibitors for cysteine protease ich-1
09/24/1997EP0796866A1 Antithrombotic diamides
09/24/1997EP0796335A1 Production of peptides using recombinant fusion protein constructs
09/24/1997EP0796271A1 New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
09/24/1997EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/24/1997EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors
09/24/1997EP0750609A4 Isoprenyl transferase inhibitors
09/24/1997EP0636143B1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
09/24/1997EP0617705B1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
09/24/1997CN1159949A Use of peptide compounds and pharmaceutically acceptable salts thereof for manufacturing medicament for treating diseases
09/23/1997US5670699 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring
09/23/1997US5670675 Retroviral protease inhibiting compounds
09/23/1997US5670637 Binding to target molecules; antibodies
09/23/1997US5670517 Multistage synthesis with epoxidation, decarbonylation, coupling by amidation then decarbonylation
09/23/1997US5670494 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
09/23/1997US5670479 α-ketoamide derivatives as inhibitors of thrombosis
09/23/1997US5670332 Enzymatic reactions and apparatus for carrying them out
09/23/1997US5670155 Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same
09/23/1997US5670133 Chemotactic peptide containing labeled metal binding ions
09/22/1997CA2200163A1 Antithrombotic diamides
09/18/1997WO1997034146A1 Inhibiting protein interactions
09/18/1997WO1997033907A1 Peptide derivatives
09/18/1997WO1997033627A2 New ternary radiopharmaceutical complexes
09/18/1997WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
09/18/1997CA2249025A1 New ternary radiopharmaceutical complexes
09/18/1997CA2248998A1 Inhibiting protein interactions
09/17/1997EP0794789A1 Inhibitors of prenyl transferases
09/17/1997CN1159758A Peptide, a method of obtaining it and a pharmaceutical compound based on it
09/16/1997US5668291 Thiosubstituted pyridines, treatment of aids and hiv
09/16/1997US5668289 Pyridinone thrombin inhibitors